View Post

Which First-Line Breast Cancer Therapy Is Right for Me?

In In The News by Barbara Jacoby

From: healthline.com You have several options for treating breast cancer, including chemo, radiation, hormone, and targeted therapies. Certain therapies may be more effective for specific types of breast cancer. After diagnosis, knowing where to turn next with your breast cancer treatment can be a tough decision. But understanding the different types of therapies available and your stage of breast cancer …

View Post

Which First-Line Breast Cancer Therapy Is Right for Me?

In In The News by Barbara Jacoby

From: healthline.com Knowing where to turn next with your breast cancer treatment can be a tough decision. But understanding the different types of therapies available for metastatic breast cancer can help ensure you know what’s best for you. Hormone and targeted therapies Hormonal therapies The first-line treatment for advanced hormone receptor-positive (estrogen receptor-positive or progesterone receptor-positive) breast cancer is usually …

View Post

First-Line Treatments for HER2-Positive Breast Cancer

In In The News by Barbara Jacoby

By: Hatem Soliman, MD From: targetedonc.com Hatem Soliman, MD, medical oncologist in The Center for Women’s Oncology and assistant member of the Experimental Therapeutics Program at Moffitt Cancer Center, discusses the current first-line treatment options for patients with HER2-positive breast cancer. According to Soliman, the phase 3 CLEOPATRA study (NCT00567190) evaluated the efficacy and safety of pertuzumab (Perjeta), trastuzumab (Herceptin), …

View Post

Current Treatment Landscape for HR+/HER2- Breast Cancer

In In The News by Barbara Jacoby

From: pharmacytimes.com Wassim McHayleh, MD, MBA, FACP: The first-line treatment of metastatic hormone-positive, HER2-negative breast cancer depends on whether the patient is endocrine resistant or endocrine sensitive. If a patient presents with de novo metastatic disease or recurs years after stopping endocrine therapy, this is an endocrine-sensitive patient. For those particular patients, the first-line treatment consists of an AI [aromatase …